NCT03753542

Brief Summary

ABSTRACT Background: Today, a wide range of pediatric cancers is treated by chemotherapy. More than 21 side effects of chemotherapy have been identified. Among those nausea; vomiting, infection and anemia are most common. The adverse effects are normally managed by the parents at home. Ineffective coping and lack of knowledge about chemotherapy side effect management leads parents stress. Contemporary research evidence that Nurse-led education, booklet providence and follow up about chemotherapy and side effect management, help to decrease parents anxiety and depression. Objectives: To measure the effect of nurse-led multimedia education, booklet providence and telephonic follow up about chemotherapy and side effects management on parents anxiety and depression of children receiving chemotherapy for the first time. Methodology: A randomized control trial will be conducted in the department of chemotherapy at Indus Children Cancer Hospital Karachi from March 2018 to August 2018 on parents of children below 18 years of age undergoing chemotherapy for the first time. Total 100 parents will be randomly divided into Intervention group (n=50) and Control Group (n=50). The Intervention group will received multimedia education, booklet and weekly tele-nursing follow-up about chemotherapy and side effects management. The Control group will receive routine care. Parent's anxiety and depression will be identified by using DASS-21 and generalized estimating estimation will be used to analyzed the data. Keywords: Nurse-led, Multimedia education, Booklet, telephonic follow-up, chemotherapy, side effects, parents, anxiety, depression, children, cancer

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 6, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 16, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 27, 2018

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2019

Completed
3.1 years until next milestone

Results Posted

Study results publicly available

July 28, 2022

Completed
Last Updated

July 28, 2022

Status Verified

July 1, 2022

Enrollment Period

4 months

First QC Date

November 16, 2018

Results QC Date

August 6, 2019

Last Update Submit

July 27, 2022

Conditions

Keywords

chemotherapy, side effects, parents, anxiety, depression

Outcome Measures

Primary Outcomes (1)

  • Depression, Anxiety and Stress Scale - 21 (DASS-21)

    DASS-21 is comprised of questionnaires for three separate scales measuring Depression, Anxiety and Stress. The depression scale is scored by summing the responses of each question, multiplying by 2 and then scoring on a scale ranging from a minimum of 0 to a maximum of 28+, with higher scores indicating greater severity. The anxiety scale is scored by summing the responses of each question, multiplying by 2 and then scoring on a scale ranging from a minimum of 0 to a maximum of 20+, with higher scores indicating greater severity. The stress scale is scored by summing the responses of each question, multiplying by 2 and then scoring on a scale ranging from a minimum of 0 to a maximum of 37+, with higher scores indicating greater severity

    up to 4 weeks

Study Arms (2)

Intervention

EXPERIMENTAL

The Intervention group will received multimedia education, booklet and weekly tele-nursing follow-up about chemotherapy and side effects management

Other: Multimedia education, booklet Providence and tele-nursing follow-up

Control

NO INTERVENTION

The Control group will receive routine care

Interventions

Multimedia education, booklet and weekly tele-nursing follow-up is about chemotherapy and side effects management

Intervention

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Parents along with their children newly diagnosed with cancer in last three weeks
  • Parents along with their children schedule to receive first time chemotherapy in the outpatient department

You may not qualify if:

  • Parents along with their children refused to participate
  • Parents along with their children already receiving interventions like multimedia education, booklet providence and telephonic follow up for chemotherapy and side effect management
  • Parents taking medicine for their anxiety and depression. (e.g. Anxiolytics/ Antidepressant)
  • Parents showing uneasiness and discomfort during educational session.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indus Children Cancer Hospital Karachi

Karachi, Sindh, Pakistan

Location

Related Publications (25)

  • Bhurgri Y, Bhurgri A, Nishter S, Ahmed A, Usman A, Pervez S, Ahmed R, Kayani N, Riaz A, Bhurgri H, Bashir I, Hassan SH. Pakistan--country profile of cancer and cancer control 1995-2004. J Pak Med Assoc. 2006 Mar;56(3):124-30. No abstract available.

    PMID: 16696512BACKGROUND
  • Ashraf MS. Pediatric oncology in Pakistan. J Pediatr Hematol Oncol. 2012 Mar;34 Suppl 1:S23-5. doi: 10.1097/MPH.0b013e318249abf9.

    PMID: 22357147BACKGROUND
  • CCHK. Children cancer Hospital karachi. 2017 [cited 2017; Available from: http://ccfpakistan.org/.

    BACKGROUND
  • Klein CA. Cancer. The metastasis cascade. Science. 2008 Sep 26;321(5897):1785-7. doi: 10.1126/science.1164853. No abstract available.

    PMID: 18818347BACKGROUND
  • Mansoor, S. and S. Jehangir, Anxiety, depression in patient receving chemotherapy for solid tumors. Pak Armed Forces Med. J, 2015. 65(1): p. 89-93.

    BACKGROUND
  • Iqbal A, Siddiqui KS. Depression among parents of children with acute lymphoblastic leukemia. J Ayub Med Coll Abbottabad. 2002 Apr-Jun;14(2):6-9.

    PMID: 12238347BACKGROUND
  • Borsellino M, Young MM. Anticipatory coping: taking control of hair loss. Clin J Oncol Nurs. 2011 Jun;15(3):311-5. doi: 10.1188/11.CJON.311-315.

    PMID: 21624866BACKGROUND
  • Graca Pereira M, Figueiredo AP, Fincham FD. Anxiety, depression, traumatic stress and quality of life in colorectal cancer after different treatments: A study with Portuguese patients and their partners. Eur J Oncol Nurs. 2012 Jul;16(3):227-32. doi: 10.1016/j.ejon.2011.06.006. Epub 2011 Jul 23.

    PMID: 21783416BACKGROUND
  • Pouresmail, Z., S. Sharafi, and M. Razi, The Role of Evidence Based Nursing in Prevention of Gastrointestinal Side Effects of Chemotherapy in Children with Cancer. International Journal of Pediatrics, 2014. 2(2.1): p. 48-48

    BACKGROUND
  • Mohammed, H.A., Impact of proposed nursing rehabilitation program on self management of selected side effects of chemotherapy for elderly patints with gastrointestinal cancer. CU Theses, 2012.

    BACKGROUND
  • Munir F, Burrows J, Yarker J, Kalawsky K, Bains M. Women's perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study. J Clin Nurs. 2010 May;19(9-10):1362-70. doi: 10.1111/j.1365-2702.2009.03006.x.

    PMID: 20500346BACKGROUND
  • Garcia S. The effects of education on anxiety levels in patients receiving chemotherapy for the first time: an integrative review. Clin J Oncol Nurs. 2014 Oct;18(5):516-21. doi: 10.1188/14.CJON.18-05AP.

    PMID: 25164233BACKGROUND
  • Hoon LS, Chi Sally CW, Hong-Gu H. Effect of psychosocial interventions on outcomes of patients with colorectal cancer: a review of the literature. Eur J Oncol Nurs. 2013 Dec;17(6):883-91. doi: 10.1016/j.ejon.2013.05.001. Epub 2013 Jun 4.

    PMID: 23759360BACKGROUND
  • Lerdkiattikorn, P., et al., Quality of life among stage III colon cancer patients receiving oral and intravenous chemotherapy regimens in Thailand. Mahidol University Journal of Pharmaceutical Sciences, 2012. 39: p. 41-3.

    BACKGROUND
  • Kutlu, R., et al., Kanserli hastalarda depresyon ve yaşam kalitesini etkileyen faktörler. Selçuk Üniv Tıp Derg, 2011. 27(3): p. 149-153

    BACKGROUND
  • Gullatte M. American Society of Clinical Oncology/Oncology Nursing Society chemotherapy safety standards. J Oncol Pract. 2013 Mar;9(2 Suppl):3s-4s. doi: 10.1200/JOP.2012.000862.

    PMID: 24135010BACKGROUND
  • Network, N.C.C. Distress management. In NCCN Clinical Practice Guidelines in Oncology. . 2017; Available from: http://www.nccn.org.

    BACKGROUND
  • Leighl N, Gattellari M, Butow P, Brown R, Tattersall MH. Discussing adjuvant cancer therapy. J Clin Oncol. 2001 Mar 15;19(6):1768-78. doi: 10.1200/JCO.2001.19.6.1768.

    PMID: 11251008BACKGROUND
  • Williams SA, Schreier AM. The effect of education in managing side effects in women receiving chemotherapy for treatment of breast cancer. Oncol Nurs Forum. 2004 Jan-Feb;31(1):E16-23. doi: 10.1188/04.ONF.E16-E23.

    PMID: 14722602BACKGROUND
  • Yasin, Y.M. and A. Al-Hamad, ANXIETY AND DEPRESSION AS KEY DETERMINANTS OF CANCER RELATED FATIGUE AMONG PATIENTS RECEIVING CHEMOTHERAPY. European Scientific Journal, ESJ, 2015. 11(33)

    BACKGROUND
  • Manir KS, Bhadra K, Kumar G, Manna A, Patra NB, Sarkar SK. Fatigue in breast cancer patients on adjuvant treatment: course and prevalence. Indian J Palliat Care. 2012 May;18(2):109-16. doi: 10.4103/0973-1075.100826.

    PMID: 23093826BACKGROUND
  • Heidari H, Hasanpour M, Fooladi M. The experiences of parents with infants in Neonatal Intensive Care Unit. Iran J Nurs Midwifery Res. 2013 May;18(3):208-13.

    PMID: 23983756BACKGROUND
  • Haugan G, Drageset J. The hospital anxiety and depression scale--dimensionality, reliability and construct validity among cognitively intact nursing home patients. J Affect Disord. 2014 Aug;165:8-15. doi: 10.1016/j.jad.2014.04.042. Epub 2014 Apr 24.

    PMID: 24882171BACKGROUND
  • Sarafraz Nasab, M. and M. Mojtabaie, P116: Reminiscence Therapy Efficacy in Reducing Symptoms of Anxiety in Elderly Nursing Home Residents in Tehran. The Neuroscience Journal of Shefaye Khatam, 2014. 2(3): p. 140-140.

    BACKGROUND
  • Zakerimoghadam, M., S. Ghiasvandian, and P. Salahshoor, The effect of supportive nursing program on depression, anxiety and stress of family members of patients during coronary artery bypass graft (CABG) surgery. Iranian Journal of Cardiovascular Nursing, 2014. 3(1): p. 50-58

    BACKGROUND

MeSH Terms

Conditions

Anxiety DisordersDepression

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Limitations and Caveats

As the study was conducted in single setting, hence the result may not be generalized. Further studies are recommended to measure its general effect.

Results Point of Contact

Title
Nomi Waqas Gul, Student MSN DUHS ION and Asst. Controller Sindh Nurses Examination Board, Karachi
Organization
Institute of Nursing Dow University of Health Sciences, Karachi/Sindh Nurses Examination Board, Karachi

Study Officials

  • Dr. Mehwish HUSSAIN, PhD (Statistics)

    Assistant Professor, DUHS, Karachi

    STUDY CHAIR
  • Dr. SHAMVIL ASHRAF, MBBS, DCH, MCPS, FCPS, MRCP

    Indus Hospital Karachi

    STUDY CHAIR
  • Mr. Hakim Shah, MSN

    Associate Professor Institute of Nursing Dow University of Health Sciences Karachi

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 16, 2018

First Posted

November 27, 2018

Study Start

September 6, 2018

Primary Completion

December 30, 2018

Study Completion

June 15, 2019

Last Updated

July 28, 2022

Results First Posted

July 28, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

No plan

Locations